An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
Ikuto Masakane(Yamagata University Hospital), Kosaku Nitta(Tokyo Women's Medical University), Kenji Wakai(Japanese Society for Dialysis Therapy), Shigeru Nakai(Japanese Society for Dialysis Therapy), Norio Hanafusa(Nihon University), Naoki Kimata(Japanese Society for Dialysis Therapy), Takayuki Hamano(Nagoya City University), Atsushi Wada(Japanese Society for Dialysis Therapy), Satoshi Ogata(Japanese Society for Dialysis Therapy)
Cited by 425
Related Papers
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
|Science Translational Medicine|2009|434
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis
|European Heart Journal|2018|323
Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008)
|Therapeutic Apheresis and Dialysis|2010|228
Overview of Regular Dialysis Treatment in <scp>J</scp>apan (as of 31 <scp>D</scp>ecember 2011)
|Therapeutic Apheresis and Dialysis|2013|198